Scrip’s Five Must-Know Things – 11 October 2023

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Lilly’s radiopharmaceutical buy; strong third quarter for biotech financing; Novartis’s nephropathy results; US ICER runs cost analysis on first batch of drugs; and the outlook for US FTC oversight of biopharma M&A. https://scrip.citeline.com/SC149170/Quick-Listen-Scrips-Five-MustKnow-Things